In the univariable survival analyses of the TNBC cohorts with CAV1 expression, there was some evidence that CAV1-high in SCAN-B was associated with increased incidence of recurrence HR 1.46 (95% CI 0.99–2.14), distant metastasis HR 1.40 (95% CI 0.90–2.18), and death HR 1.33 (95% CI 0.97–1.84), Fig 4A, 4C, 4E. The gene discussed is CAV1; the disease is spinocerebellar ataxia, autosomal recessive, with axonal neuropathy.